Figure 3
From: Stabilization of ferulic acid in topical gel formulation via nanoencapsulation and pH optimization

PXRD profile of ferulic acid (active), Gelucire 50/13 (lipid excipient), empty nanocapsule (ferulic acid free), and nanoencapsulated ferulic acid.